ADNCD
   
 
 
Select Mode of Action
Anti-diabetic mode of action: Insulin Sensitizers
Adenosine Monophosphate-Activated Protein Kinase activators (AMPK activators)
S.No. Compound Reference Physicochemical Properties and Toxicity Risks
1 Metformin(Known Drug)Zhou et al. 2001, Hawley et al., 2002 Properties and Risk Assessment
2 Phenformin(Known Drug)Yang et al., 2013 Properties and Risk Assessment
3 3-Caffeoylquinic AcidZhang et al., 2013 Properties and Risk Assessment
4 BerberineZheng et al., 2014 Chen et al., 2010 Properties and Risk Assessment
5 CapsaicinKwon et al., 2013 Properties and Risk Assessment
6 Chlorogenic AcidOng et al., 2013 Properties and Risk Assessment
7 DehydropipernonalineKim et al., 2011 Properties and Risk Assessment
8 Epigallocatechin3-GallateCollins et al., 2007 Properties and Risk Assessment
9 GalegineMadiraju et al., 2014 Properties and Risk Assessment
10 GenisteinHwang et al., 2005 Properties and Risk Assessment
11 Ginsenoside Rg3Park et al., 2008 Properties and Risk Assessment
12 HonokiolFried and Arbiser et al., 2009 Properties and Risk Assessment
13 KaempferolAlkhalidy et al., 2015 Properties and Risk Assessment
14 Lipoic acidGolbidi et al., 2011 Properties and Risk Assessment
15 PiperineKim et al., 2011 Properties and Risk Assessment
16 PipernonalineKim et al., 2011 Properties and Risk Assessment
17 QuercetinAhn et al., 2008 Properties and Risk Assessment
18 ResveratrolSzkudelski and Szkudelska, 2015 Properties and Risk Assessment
19 Salicylic acidRena and Sakamoto, 2014 Properties and Risk Assessment
20 TangeretinKims et al., 2012 Properties and Risk Assessment
21 Tormentic AcidWu et al., 2014 Properties and Risk Assessment